Filing Flows › Comparisons › CNTB vs EVFM
Connect Biopharma Holdings vs Evofem Biosciences: CNTB and EVFM compared
Connect Biopharma Holdings is the larger company: $2.8M of revenue in its latest quarter (Q2 2026) against $2.6M for Evofem Biosciences (Q2 2026). Connect Biopharma Holdings is growing faster (58× against -45% a year earlier). Evofem Biosciences is more profitable, with an operating margin of -94.5% against -636.0%.
Where the money goes: CNTB and EVFM
Connect Biopharma Holdings (CNTB) · Q2 2026
Connect Biopharma Holdings, Q2 2026: revenue $2.8M (58× year over year), operating margin -636.0%, net loss $17.3M, operating cash flow −$15.9M. The chart follows the revenue to costs, profit and cash.
Evofem Biosciences (EVFM) · Q2 2026
Evofem Biosciences, Q2 2026: revenue $2.6M (-45% year over year), operating margin -94.5%, net loss $11.0M, operating cash flow −$3.1M. The chart follows the revenue to costs, profit and cash.
| Connect Biopharma Holdings (CNTB) | Evofem Biosciences (EVFM) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $2.8M | $2.6M |
| Revenue growth, Y/Y | 58× | -45% |
| Operating margin | -636.0% | -94.5% |
| Net earnings | −$17.3M | −$11.0M |
| Net margin | -624.4% | -419.1% |
| Operating cash flow | −$15.9M | −$3.1M |
Questions
Which is bigger, Connect Biopharma Holdings or Evofem Biosciences?
Connect Biopharma Holdings is the larger company: $2.8M of revenue in its latest quarter (Q2 2026) against $2.6M for Evofem Biosciences (Q2 2026).
Is Connect Biopharma Holdings or Evofem Biosciences growing faster?
Connect Biopharma Holdings is growing faster (58× against -45% a year earlier).
Which is more profitable, Connect Biopharma Holdings or Evofem Biosciences?
Evofem Biosciences is more profitable, with an operating margin of -94.5% against -636.0%.
More: Connect Biopharma Holdings earnings · how Connect Biopharma Holdings makes money · Evofem Biosciences earnings · how Evofem Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 12, 2026; 10-Q filed Aug 14, 2026). Fiscal quarters can end on different dates. Not investment advice.